Pharmaleads
PrivateLast Round
VC Round
Oct 16, 2014
Company Overview
Pharmaleads is a biotechnology company that develops non-opiate, non-addictive small molecule therapeutics for the management of acute and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharmaleads Comparables
Compare Pharmaleads with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IACTA Pharmaceuticals | 85% | |
| Latigo Biotherapeutics | 85% | |
| Algiax Pharmaceuticals | 82% |
Pharmaleads Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 16, 2014 | ||||
| Seed | Dec 1, 2000 |
Key People
Founding team and executive leadership
Pharmaleads Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofinnova Partners | VC Round |
| iXLife Capital | VC Round |
| Bpifrance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2024
Monthly visitors increased 30% MoM.
Pharmaleads Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pharmaleads's valuation, stock price, and market status.
Is Pharmaleads a public or private company?
Pharmaleads is a private company.
What is the current stock price of Pharmaleads?
Pharmaleads is a private company with no public stock price. No recent secondary market data is available.
How much is Pharmaleads worth (valuation)?
Valuation information for Pharmaleads is not publicly available.
Can I buy Pharmaleads stock?
Pharmaleads shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pharmaleads's last funding round?
Pharmaleads's most recent funding round was VC Round on October 16, 2014.
Who are the main investors in Pharmaleads?
Key investors in Pharmaleads include Sofinnova Partners, iXLife Capital, Bpifrance.
Will Pharmaleads IPO soon?
No public IPO plans have been announced for Pharmaleads.
How can I track Pharmaleads secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharmaleads's secondary market activity and sign up for updates.